ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
PLK1 inhibition-based combination therapies for cancer management
Translational Oncology
◽
10.1016/j.tranon.2021.101332
◽
2022
◽
Vol 16
◽
pp. 101332
Author(s):
Shengqin Su
◽
Gagan Chhabra
◽
Chandra K. Singh
◽
Mary A. Ndiaye
◽
Nihal Ahmad
Keyword(s):
Combination Therapies
◽
Cancer Management
Download Full-text
Related Documents
Cited By
References
Two Combination Therapies Equal for Acne
Internal Medicine News
◽
10.1016/s1097-8690(10)70741-1
◽
2010
◽
Vol 43
(14)
◽
pp. 35
Author(s):
HEIDI SPLETE
Keyword(s):
Combination Therapies
Download Full-text
Combination therapies in the treatment of sexual dysfunction
PsycEXTRA Dataset
◽
10.1037/e512622013-006
◽
2011
◽
Author(s):
Michael A. Perelman
Keyword(s):
Sexual Dysfunction
◽
Combination Therapies
Download Full-text
Combination Therapies Equal For Reducing Acne Lesions
Family Practice News
◽
10.1016/s0300-7073(10)70964-6
◽
2010
◽
Vol 40
(15)
◽
pp. 56
Author(s):
HEIDI SPLETE
Keyword(s):
Combination Therapies
Download Full-text
New combination therapies for castration-resistant prostate cancer
Oncology Abstracts
◽
10.1530/oncolabs.1.p031
◽
2019
◽
Author(s):
Mitchell G Lawrence
◽
Laura H Porter
◽
Daisuke Obinata
◽
Shahneen Sandhu
◽
Luke A Selth
◽
...
Keyword(s):
Prostate Cancer
◽
New Combination
◽
Combination Therapies
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Submit Manuscript | http://medc rav eonline.co m Introduction Colorectal adenocarcinoma is the third most common malignant neoplasia and the third leading cause of death from cancer in men and women in the United States. Current data show that the incidence of colorectal adenocarcinoma is decreasing in developed countries but increasing in developing countries. 1 The 2018 estimates of the Bra - zilian National Cancer Institute (Instituto Nacional do Câncer–INCA) were 17,380 new cases in men and 18,980 in women, making col - orectal adenocarcinoma the third most common neoplasia in men and the second most common in women in Brazil. 2 In the past 15 years, rectal cancer management has evolved in several aspects. Specifical - ly, a better understanding of the natural history of the disease, more precise radiological staging, multimodal therapeutic intervention, refined surgical techniques, and more detailed histopathological re - ports may have positively influenced patient survival. In this context, multidisciplinary management of colorectal cancer plays an important role and requires the coordinated teamwork of colorectal surgeons, oncologists, radiologists, and radiotherapists. 3 Total mesorectal exci - sion is still the basis of treatment in rectal cancer. However, neoadju - vant therapy and more conservative practices have been adopted in cases of clinical/pathological responses to radiochemotherapy. 4 Ra - diological evaluation of the response is of paramount importance for the selection of patients eligible for alternative treatment strategies, including ‘watch-and-wait’. Diffusion-weighted imaging is already being used routinely in the evaluation of the pathological response of rectal tumour patients submitted to neoadjuvant therapy. Some re - searchers have tried to estimate the tumour regression grade (TRG) using magnetic resonance imaging, as has been described for post-ra - diochemotherapy pathological evaluation, thus rendering it a valuable instrument. Considering the good results obtained with multimodal therapy in extraperitoneal rectal cancer, the evaluation of the pathological re - sponse post-neoadjuvant therapy must be considered as a factor for safe indication, both for the conservative option, in which the organ is preserved, and for radical surgical resection, influencing the choice between sphincter-preserving surgery and abdominoperineal excision. A precise evaluation, by comparing the results of post-neoadjuvant therapy magnetic resonance imaging with those obtained from his - Int J Radiol Radiat Ther. 2018;5(4):254 ‒ 258. 254 © 2018 Oliveira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially. Magnetic resonance imaging is effective in assessing tumour regression after neoadjuvancy in rectal adenocarcinoma
International Journal of Radiology & Radiation Therapy
◽
10.15406/ijrrt.2018.05.00173
◽
2018
◽
Vol 5
(4)
◽
Author(s):
Fábio Henrique de Oliveira
◽
Antônio Lacerda-Filho
◽
Fábio Lopes de Queiroz
◽
Tatiana Martins Gomide Leite
◽
Paulo Guilherme Oliveira Sales
◽
...
Keyword(s):
Magnetic Resonance Imaging
◽
Rectal Cancer
◽
Magnetic Resonance
◽
Neoadjuvant Therapy
◽
Colorectal Adenocarcinoma
◽
The United States
◽
Tumour Regression
◽
Resonance Imaging
◽
Cancer Management
◽
The Third
Download Full-text
The Role Of The Clergy In Cancer Management And Rehabilitation
10.2986/tren.100-0032
◽
1979
◽
Author(s):
Emmett M. WAITS
Keyword(s):
Cancer Management
Download Full-text
A Study by the Development of Triple Artemisinin Combination Therapies (DeTACT) Collaboration (Africa)
Case Medical Research
◽
10.31525/ct1-nct03923725
◽
2019
◽
Author(s):
Keyword(s):
Combination Therapies
◽
Artemisinin Combination Therapies
Download Full-text
Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13690956.793153050
◽
2012
◽
Author(s):
Hendrik van Poppel
◽
Yuri Tolkach
Keyword(s):
Prostate Cancer
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Cancer Management
◽
Prostate Cancer Management
Download Full-text
Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13690956.15750058
◽
2012
◽
Author(s):
Yoshihiko Hirao
◽
Kiyohide Fujimoto
Keyword(s):
Prostate Cancer
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Cancer Management
◽
Prostate Cancer Management
Download Full-text
Faculty Opinions recommendation of Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.3447957.3171054
◽
2010
◽
Author(s):
Takahiko Nakagawa
Keyword(s):
High Risk
◽
Randomised Controlled Trial
◽
Cardiovascular Events
◽
Controlled Trial
◽
Secondary Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Combination Therapies
◽
Dose Combination
◽
Randomised Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close